Acrinova AB (publ) Class A (9M0) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	32.39M	12.62M	13.85M	13.19M
Cost of goods sold	17.48M	6.76M	7.34M	4.70M
Cost of revenue	17.48M	6.76M	7.34M	4.70M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.31M	5.23M	4.21M	4.15M
Operating expense	4.31M	7.24M	4.21M	4.15M
Total operating expenses	21.80M	13.99M	11.55M	8.85M
Operating income	10.59M	-1.37M	2.30M	4.34M
Other non operating income	-8.45M	1.63M	2.22M	-4.07M
EBT including unusual items	-36.58M	33.94M	-2.33M	-1.05M
EBT excluding unusual items	-1.86M	-1.73M	2.26M	-2.77M
Income tax expense	-53.74M	15.00M	-3.20M	-245.00K
Effective tax rate	146.94%	44.20%	137.31%	23.24%
Other operating expenses	-	-	-	-
Net income	17.17M	18.94M	869.00K	-809.00K
Net profit margin	53.01%	149.99%	6.27%	-6.13%
Earnings per share	-	-	-	-
Interest and investment income	932.00K	12.98M	1.11M	449.00K
Interest expense	-4.94M	-14.97M	-3.38M	-3.49M
Net interest expenses	-4.01M	-1.99M	-2.27M	-3.04M
Depreciation and amortization charges	-	2.00M	-	-
EBITDA	10.93M	-868.50K	2.81M	4.84M
Gain or loss from assets sale	-	-	-	-

Ask anything